Citation: | FEI Huizhi, HU Xiaoya, QIU Hongmei, LIU Dan, ZHOU Qixin. Improvement of NET and 5-HTT expression involved in the anti-depressive effect of valproate[J]. Journal of China Pharmaceutical University, 2016, 47(4): 474-478. DOI: 10.11665/j.issn.1000-5048.20160414 |
[1] |
World Health Organization.Fact sheets N° 369:depression[EB/OL].(2015-10-01)[2016-01-04] .http://www.who.int/mediacentre/factsheets/fs369/en/.html.
|
[2] |
Dedovic K,Duchesne A,Engert V,et al.Psychological,endocrine and neural responses to social evaluation in subclinical depression[J]. Soc Cogn Affect Neurosci,2014,9(10): 1632-1644.
|
[3] |
Quesseveur G,Gardier AM,Guiard BP.The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs[J].Curr Drug Targets,2013,14(11):1277-1294.
|
[4] |
Fornaro M,McCarthy MJ,DeBerardis D,et al.Adjunctive agomelatine therapy in the treatment of acute bipolar II depression:a preliminary open label study[J].Neuropsych Dis Treat,2013,9:243-251.
|
[5] |
Xie JP,Ren ZB,Ma YC,et al.Comparing study on therapeutic of outpatients with agitated or anxiety depression by combination of SSRI and sodium valproate RX [J].Chin J Clin Pharm Ther(中国临床药理学与治疗学),2013,18(1):86-89.
|
[6] |
Unterecker S,Reif A,Hempel S,et al.Interaction of valproic acid and the antidepressant drugs doxepin and venlafaxine:analysis of therapeutic drug monitoring data under naturalistic conditions[J].Int Clin Psychopharma,2014,29(4):206-211.
|
[7] |
Maes M,Kubera M,Obuchowiczwa E,et al.Depression′s multiple comorbidities explained by(neuro)inflammatory and oxidative & nitrosative stress pathways[J].Neuro Endocrinol Lett,2011,32(1):7-24.
|
[8] |
Hu XY,Li N,Fei HZ,et al.Anti-depressive effect of reboxetine on non-transporter inhibition in rats[J].Acta Acad Med Mil Tert(第三军医大学学报),2012,34(19):1977-1980.
|
[9] |
Fei HZ,Wang H,Hu XY,et al. Improvement of oxidative stress and HPA axis function and elevation of BDNF expression involved in anti-depressive effect of paroxetine in rat model[J].Chin J Clin Pharm Ther(中国临床药理学与治疗学),2012,17(10):1137-1142.
|
[10] |
Tang M,Lei JY,Sun X,et al.Stress-induced anhedonia correlates with lower hippocampal serotonin transporter protein expression[J].Brain Res,2013,1513:127-134.
|
[11] |
Chen P, Fan Y, Li Y, et al. Chronic social defeat up-regulates expression of norepinephrine transporter in rat brains[J].Neurochem Int,2012,60(1):9-20.
|
[12] |
Li N,Wang H,Wen W,et al.Improvement of oxidative/anti-oxidative stress balance and expression of NET and 5-HTT involve in the anti-depressive effect of reboxetine[J].Clin Pharmocal Bull(中国药理学通报),2011,27(9):593-597.
|
[13] |
Hu XY, Fei HZ, Jiang XH, et al. Improving oxidative stress response and reversing abnormal expression of hippocampus NET and 5-HTT involved in anti-depressive effect of venlafaxine[J].Clin Pharmocal Bull(中国药理学通报),2014,30(6):848-852.
|
[14] |
Wang LJ,Qiu HM,Jiang XH,et al.Down-regulation of monoamine neurotransmitter synthetase expression involved in CUS-induced depression of rats[J].Chin Pharmacol Bull(中国药理学通报),2015,31(4):527-531.
|
[15] |
Qin LJ,Liu D,Jiang XH,et al.Down-regulation of hyppocampal TH and TPH expression involved in CUMS induced depressive behaviors of rats and interfering effects of venlafaxine[J].Chin J Clin Pharm Ther(中国临床药理学与治疗学),2014,19(4):398-403.
|
[1] | ZHAO Xiaomei, WANG Xin, JI Xia, Zhang Jing, ZHANG Hua, HU Guoqiang. Synthesis and antitumor activity of heteroatom-substituted azulenes derivatives of 1,2-benzothiazine[J]. Journal of China Pharmaceutical University, 2024, 55(5): 634-638. DOI: 10.11665/j.issn.1000-5048.2023120503 |
[2] | SUN Dongyu, GONG Jingxu, LI Xuwen, HAN Guanying, GUO Yuewei. Studies on methyl xestopongoate analogues:design, synthesis and antitumor activities[J]. Journal of China Pharmaceutical University, 2018, 49(4): 413-421. DOI: 10.11665/j.issn.1000-5048.20180405 |
[3] | LI Mingtao, XU Dan, XUE Wenjun, YOU Qidong, SUN Liping. Design, synthesis and antitumor activities of oxazolo[5, 4-d]pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(4): 425-431. DOI: 10.11665/j.issn.1000-5048.20170406 |
[4] | QIAO Yixue, MOU Yi, HUANG Zhangjian, AI Yong, KANG Fenghua, LAI Yisheng, ZHANG Yihua. Synthesis and antitumor activities of novel CDDO-Me analogues[J]. Journal of China Pharmaceutical University, 2015, 46(3): 289-293. DOI: 10.11665/j.issn.1000-5048.20150305 |
[5] | MAO Chunfang, XU Chenjun, WANG Xuemin, LI Xianghua, ZHANG Wei, WANG Xinyang, LING Yong. Design, synthesis and antitumor activity of farnesylthiosalicylamide derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(2): 162-168. DOI: 10.11665/j.issn.1000-5048.20150204 |
[6] | HU Kun, ZHOU Anfei, JIANG Hefei, XU Yuanyuan, HUANG Qianhui, YANG Jie, CHEN Xin, REN Jie. Synthesis and antitumor activities of podophyllotoxin derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 33-38. DOI: 10.11665/j.issn.1000-5048.20140105 |
[7] | CHENG Keguang, CHU Xiangwu, LIU Guanyan, SU Chunhua, DENG Shengping, PAN Hongmei. Synthesis and antitumor activities of 3-substituted estradiol-pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 26-32. DOI: 10.11665/j.issn.1000-5048.20140104 |
[8] | LIU Dexiu, PAN Huaying, SHI Hui, HUANG Xiaoying, LOU Hongxiang. Synthesis and antitumor activity of a novel bisbibenzyl derivative[J]. Journal of China Pharmaceutical University, 2013, 44(6): 515-519. DOI: 10.11665/j.issn.1000-5048.20130605 |
[9] | HU Kun, XU Hua-jin, XIN Wen-qun, CHEN Xin, REN Jie. Synthesis and antitumor activity of nitrogen mustard derivatives of formononetin[J]. Journal of China Pharmaceutical University, 2012, 43(2): 113-119. |
[10] | ZHA Xiao-ming, ZHANG Fei-ran, SHAN Jia-qi, CHEN Yan-ke, ZHANG Yi-hua, LIU Jun, SUN Hong-bin. Synthesis and in vitro antitumor activities of novel soladulcidine derivatives[J]. Journal of China Pharmaceutical University, 2010, 41(6): 493-498. |